On November 27, 2013, the Drug Quality Security Act (DQSA) created a new section 503B in the Federal Food, Drug, and Cosmetic Act (FDCA). Under section 503B, a compounding pharmacy can become an outsourcing facility.
Outsourcing facilities must comply with current good manufacturing practice (CGMP) requirements and will be inspected by the FDA.
Request 503B Outsourcing Facilities Services